Review



biotin  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Miltenyi Biotec biotin
    Biotin, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 69 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd31/CD31+Antibody%2C+anti-mouse/pmc13101284-4-3-8
    Average 95 stars, based on 69 article reviews
    biotin - by Bioz Stars, 2026-11
    95/100 stars

    Images

    Related Articles

    Single Cell:

    Article Title: Oxidative Stress-Induced Microglial CD22 Upregulation Impairs Phagocytosis and Exacerbates Huntington’s Disease
    Article Snippet: Myelin was removed by resuspending cell pellets in 0.9 M sucrose in DPBS with calcium and magnesium (Gibco; 14040) and centrifuging (850 xg, 15 minutes, 4 °C). .. The single cell suspension was first blocked with 1:65 Fc block (BD Pharmingen; 553142) for 10 minutes on ice before being stained with 1:10 CD90.2/Thy-1.2–APC/FireTM (BioLegend; 105348), 1:50 ACSA2–PE-Vio ® 770 (Miltenyi Biotec; 130-116-246), 1:200 CD11b–BV421 (BioLegend; 101236), 1:10 anti-Galactocerebroside–FITC (Merck Milli-Mark ® ; FCMAB312F), 1:50 CD31–APC (Miltenyi Biotec; 130-123-813), and 1:1000 Fixable Viability Dye eFluorTM506 (Invitrogen eBioscienceTM; 65-0866-14). .. The single cell suspension was first blocked with 1:65 Fc block (BD Pharmingen; 553142) for 10 minutes on ice before being stained with 1:10 CD90.2/Thy-1.2–APC/Fire (BioLegend; 105348), 1:50 ACSA2–PE-Vio 770 (Miltenyi Biotec; 130-116-246), 1:200 CD11b–BV421 (BioLegend; 101236), 1:10 anti-Galactocerebroside–FITC (Merck Milli-Mark ; FCMAB312F), 1:50 CD31–APC (Miltenyi Biotec; 130-123-813), and 1:1000 Fixable Viability Dye eFluor506 (Invitrogen eBioscience; 65-0866-14).

    Suspension:

    Article Title: Oxidative Stress-Induced Microglial CD22 Upregulation Impairs Phagocytosis and Exacerbates Huntington’s Disease
    Article Snippet: Myelin was removed by resuspending cell pellets in 0.9 M sucrose in DPBS with calcium and magnesium (Gibco; 14040) and centrifuging (850 xg, 15 minutes, 4 °C). .. The single cell suspension was first blocked with 1:65 Fc block (BD Pharmingen; 553142) for 10 minutes on ice before being stained with 1:10 CD90.2/Thy-1.2–APC/FireTM (BioLegend; 105348), 1:50 ACSA2–PE-Vio ® 770 (Miltenyi Biotec; 130-116-246), 1:200 CD11b–BV421 (BioLegend; 101236), 1:10 anti-Galactocerebroside–FITC (Merck Milli-Mark ® ; FCMAB312F), 1:50 CD31–APC (Miltenyi Biotec; 130-123-813), and 1:1000 Fixable Viability Dye eFluorTM506 (Invitrogen eBioscienceTM; 65-0866-14). .. The single cell suspension was first blocked with 1:65 Fc block (BD Pharmingen; 553142) for 10 minutes on ice before being stained with 1:10 CD90.2/Thy-1.2–APC/Fire (BioLegend; 105348), 1:50 ACSA2–PE-Vio 770 (Miltenyi Biotec; 130-116-246), 1:200 CD11b–BV421 (BioLegend; 101236), 1:10 anti-Galactocerebroside–FITC (Merck Milli-Mark ; FCMAB312F), 1:50 CD31–APC (Miltenyi Biotec; 130-123-813), and 1:1000 Fixable Viability Dye eFluor506 (Invitrogen eBioscience; 65-0866-14).

    Blocking Assay:

    Article Title: Oxidative Stress-Induced Microglial CD22 Upregulation Impairs Phagocytosis and Exacerbates Huntington’s Disease
    Article Snippet: Myelin was removed by resuspending cell pellets in 0.9 M sucrose in DPBS with calcium and magnesium (Gibco; 14040) and centrifuging (850 xg, 15 minutes, 4 °C). .. The single cell suspension was first blocked with 1:65 Fc block (BD Pharmingen; 553142) for 10 minutes on ice before being stained with 1:10 CD90.2/Thy-1.2–APC/FireTM (BioLegend; 105348), 1:50 ACSA2–PE-Vio ® 770 (Miltenyi Biotec; 130-116-246), 1:200 CD11b–BV421 (BioLegend; 101236), 1:10 anti-Galactocerebroside–FITC (Merck Milli-Mark ® ; FCMAB312F), 1:50 CD31–APC (Miltenyi Biotec; 130-123-813), and 1:1000 Fixable Viability Dye eFluorTM506 (Invitrogen eBioscienceTM; 65-0866-14). .. The single cell suspension was first blocked with 1:65 Fc block (BD Pharmingen; 553142) for 10 minutes on ice before being stained with 1:10 CD90.2/Thy-1.2–APC/Fire (BioLegend; 105348), 1:50 ACSA2–PE-Vio 770 (Miltenyi Biotec; 130-116-246), 1:200 CD11b–BV421 (BioLegend; 101236), 1:10 anti-Galactocerebroside–FITC (Merck Milli-Mark ; FCMAB312F), 1:50 CD31–APC (Miltenyi Biotec; 130-123-813), and 1:1000 Fixable Viability Dye eFluor506 (Invitrogen eBioscience; 65-0866-14).

    Staining:

    Article Title: Oxidative Stress-Induced Microglial CD22 Upregulation Impairs Phagocytosis and Exacerbates Huntington’s Disease
    Article Snippet: Myelin was removed by resuspending cell pellets in 0.9 M sucrose in DPBS with calcium and magnesium (Gibco; 14040) and centrifuging (850 xg, 15 minutes, 4 °C). .. The single cell suspension was first blocked with 1:65 Fc block (BD Pharmingen; 553142) for 10 minutes on ice before being stained with 1:10 CD90.2/Thy-1.2–APC/FireTM (BioLegend; 105348), 1:50 ACSA2–PE-Vio ® 770 (Miltenyi Biotec; 130-116-246), 1:200 CD11b–BV421 (BioLegend; 101236), 1:10 anti-Galactocerebroside–FITC (Merck Milli-Mark ® ; FCMAB312F), 1:50 CD31–APC (Miltenyi Biotec; 130-123-813), and 1:1000 Fixable Viability Dye eFluorTM506 (Invitrogen eBioscienceTM; 65-0866-14). .. The single cell suspension was first blocked with 1:65 Fc block (BD Pharmingen; 553142) for 10 minutes on ice before being stained with 1:10 CD90.2/Thy-1.2–APC/Fire (BioLegend; 105348), 1:50 ACSA2–PE-Vio 770 (Miltenyi Biotec; 130-116-246), 1:200 CD11b–BV421 (BioLegend; 101236), 1:10 anti-Galactocerebroside–FITC (Merck Milli-Mark ; FCMAB312F), 1:50 CD31–APC (Miltenyi Biotec; 130-123-813), and 1:1000 Fixable Viability Dye eFluor506 (Invitrogen eBioscience; 65-0866-14).

    Article Title: Fibroadipogenic progenitor-secreted prostaglandin E2 coordinates stem cell fate via autocrine and paracrine crosstalk in healthy and dystrophic muscle.
    Article Snippet: Muscle cells were dissociated by using the gentle MACS dissociator (Miltenyi Biotech). .. After completion of the dissociation program, the mixture was filtered successively through 100 μm and 30 μm cell strainers, and stained for 20min on ice in the dark with the following antibodies: 7-AAD (cat# 420403, 1:40, Biolegend), FITC-conjugated antibodies for anti-CD45 (cat# 130-116-500, clone 30F11, Miltenyi Biotech), anti-CD31 (cat# 130-123-675, clone 390, 1:100, Miltenyi Biotech), anti-CD11b (cat# 130-113-234, M1/ 70.15.11.5, 1:100, Miltenyi Biotech), APC-conjugated anti-Itgb1 (cat# 130- 123-829, clone HMβ1-1, 1:20, Miltenyi Biotech), PE-conjugated anti-Itga7 (cat# 130-120-812, clone 3C12, 1:100, Miltenyi Biotech), APC-Vio 770 antiPdgfra (cat# 130-126-625, clone APA5, 1:60, Miltenyi Biotech) and BV421 anti-Sca-1 (cat# 108128, clone D7, 1:100, Biolegend). .. MuSCs were isolated by FACS (BD FACSAria Fusion) using a gating strategy based on forward scatter and side scatter profiles and viability, negative for CD45, CD11b, CD31, Sca-1, Pdgfra and positive for Itgb1 and Itga7.

    other:

    Article Title: Protocol for isolating stromal cells from lymphoid tissue for performing scRNA-seq
    Article Snippet: CD31 antibody, anti-mouse, Biotin (Dilutions in 1:50) , Miltenyi Biotec , Cat# 130-119-562, RRID: AB_2751728.



    Similar Products

    94
    Sino Biological pcmv3 pecam 1 myc
    Pcmv3 Pecam 1 Myc, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd31/Human+CD31%2FPECAM-1+Gene+ORF+cDNA+clone+expression+plasmid%2C+C-Myc+tag/10__1038_slash_s41467___026___79134___z-410-20-16
    Average 94 stars, based on 1 article reviews
    pcmv3 pecam 1 myc - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc rt with cd31
    Rt With Cd31, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd31/CD31+(PECAM-1)+XP+Rabbit+mAb/pmc13752331-587-17-20
    Average 97 stars, based on 1 article reviews
    rt with cd31 - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    98
    R&D Systems cd31
    CD34 expression decreases in ageing‐associated AVS. (a) Schematic diagram showing the scRNA‐seq strategy of human aortic valves using data from the public database (PRJNA562645). (b) Left, UMAP plots of integrated scRNA‐seq datasets showing overall cell type and cluster distribution of human aortic valves (top left), and subtype and cluster distribution of valvular interstitial cell subpopulations (bottom left), from young and old patients. Coloured by cluster; Right, split UMAP plots of each group (VICs from young and old groups), coloured by cell cluster. (c) Stack bar plot showing the proportion of VIC subclusters in young and old cells. (d) Dot plot showing the representative DEGs for each VIC subcluster. (e) Bar plot showing the main enriched biological process in each VIC subcluster based on the significant DEGs from each subcluster. (f) Density plot of VIC subclusters in young and old groups across the pseudotime trajectory, coloured by VIC subcluster. (g) Violin plots displaying CD34 gene expression levels in the VIC subcluster for young and old groups. Statistical p values from Wilcoxon testing are added between the two groups. (h) CD34 gene expression trends across the pseudotime trajectory. (i) Representative immunohistochemical (IHC) images illustrating CD34 expression pattern in young and old aortic valves from mice, with magnified views of boxed regions. Dot plot (right) displayed the average optical density of CD34‐positive staining in aortic valves across different groups ( n = 6, unpaired two‐tailed Student's t‐test). Scale bars: 200 µm and 100 µm. (j) Western blotting of CD34 expression in aortic valves from young and old mice (upper panel), and control and D‐gal‐induced old mice (lower panel). (k) Quantification of fold changes associated with CD34 expression in AV tissues from young and old mice (left), and control and D‐gal induced old mice (right) ( n = 3, unpaired two‐tailed Student's t‐test). (l) Immunofluorescence (IF) staining demonstrating CD34 (red), <t>CD31(green),</t> and α SMA (grey) expression in AV tissues from human with sclerosis and stenosis, together with non‐sclerotic and non‐calcific AV tissues. Scale bars: 500 µm. Data are presented as the mean ± SEM. scRNA‐seq, single‐cell RNA sequencing; VICs, valvular interstitial cells; DEGs, differentially expressed genes.
    Cd31, supplied by R&D Systems, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd31/Human%2FMouse%2FRat+CD31%2FPECAM-1+Antibody/pmc13752233-201-16-17
    Average 98 stars, based on 1 article reviews
    cd31 - by Bioz Stars, 2026-11
    98/100 stars
      Buy from Supplier

    93
    Novus Biologicals anti cd31 mab
    Ocular tolerability following subconjunctival anti–Scg3 hAb administration. Mouse eyes were injected with either 80 µg or 2 mg of anti–Scg3 hAb and compared to PBS-treated and healthy eyes. ( A – C ) Images taken using the SMZ microscope ( A ) and OCT ( B ) were compared, and corneal thickness was quantified ( C ). ( D ) Corneal sensitivity was measured using the Cochet–Bonnet esthesiometer. ( E ) Blood vessels were immunostained using <t>anti-CD31.</t> Scale bar : 500 µm. ( F ) Vessel density was quantified. ( G , H ) Anti–ZO-1 was used for the immunostaining of tight junctions. Scale bar : 100 µm. ( I ) The number of corneal epithelial cells was counted. ( J ) Sodium fluorescein staining was used to verify the corneal epithelial integrity. Scale bar : 1000 µm. Data are presented as ±SEM; n = 5 corneas. P < 0.05 (one-way ANOVA).
    Anti Cd31 Mab, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd31/CD31%2FPECAM-1+Antibody+(MEC+7%2E46)+%5BDyLight+550%5D/pmc13760287-54-13-18
    Average 93 stars, based on 1 article reviews
    anti cd31 mab - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    Rockland Immunochemicals anti cd31 rb igg
    Ocular tolerability following subconjunctival anti–Scg3 hAb administration. Mouse eyes were injected with either 80 µg or 2 mg of anti–Scg3 hAb and compared to PBS-treated and healthy eyes. ( A – C ) Images taken using the SMZ microscope ( A ) and OCT ( B ) were compared, and corneal thickness was quantified ( C ). ( D ) Corneal sensitivity was measured using the Cochet–Bonnet esthesiometer. ( E ) Blood vessels were immunostained using <t>anti-CD31.</t> Scale bar : 500 µm. ( F ) Vessel density was quantified. ( G , H ) Anti–ZO-1 was used for the immunostaining of tight junctions. Scale bar : 100 µm. ( I ) The number of corneal epithelial cells was counted. ( J ) Sodium fluorescein staining was used to verify the corneal epithelial integrity. Scale bar : 1000 µm. Data are presented as ±SEM; n = 5 corneas. P < 0.05 (one-way ANOVA).
    Anti Cd31 Rb Igg, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd31/CD31+Antibody/pm42984393-98-10-14
    Average 93 stars, based on 1 article reviews
    anti cd31 rb igg - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc rabbit primary antibody against pecam
    Ocular tolerability following subconjunctival anti–Scg3 hAb administration. Mouse eyes were injected with either 80 µg or 2 mg of anti–Scg3 hAb and compared to PBS-treated and healthy eyes. ( A – C ) Images taken using the SMZ microscope ( A ) and OCT ( B ) were compared, and corneal thickness was quantified ( C ). ( D ) Corneal sensitivity was measured using the Cochet–Bonnet esthesiometer. ( E ) Blood vessels were immunostained using <t>anti-CD31.</t> Scale bar : 500 µm. ( F ) Vessel density was quantified. ( G , H ) Anti–ZO-1 was used for the immunostaining of tight junctions. Scale bar : 100 µm. ( I ) The number of corneal epithelial cells was counted. ( J ) Sodium fluorescein staining was used to verify the corneal epithelial integrity. Scale bar : 1000 µm. Data are presented as ±SEM; n = 5 corneas. P < 0.05 (one-way ANOVA).
    Rabbit Primary Antibody Against Pecam, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd31/CD31+(PECAM-1)+XP+Rabbit+mAb/pm42988040-82-15-20
    Average 97 stars, based on 1 article reviews
    rabbit primary antibody against pecam - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc rabbit monoclonal anti cd31 ihc
    Ocular tolerability following subconjunctival anti–Scg3 hAb administration. Mouse eyes were injected with either 80 µg or 2 mg of anti–Scg3 hAb and compared to PBS-treated and healthy eyes. ( A – C ) Images taken using the SMZ microscope ( A ) and OCT ( B ) were compared, and corneal thickness was quantified ( C ). ( D ) Corneal sensitivity was measured using the Cochet–Bonnet esthesiometer. ( E ) Blood vessels were immunostained using <t>anti-CD31.</t> Scale bar : 500 µm. ( F ) Vessel density was quantified. ( G , H ) Anti–ZO-1 was used for the immunostaining of tight junctions. Scale bar : 100 µm. ( I ) The number of corneal epithelial cells was counted. ( J ) Sodium fluorescein staining was used to verify the corneal epithelial integrity. Scale bar : 1000 µm. Data are presented as ±SEM; n = 5 corneas. P < 0.05 (one-way ANOVA).
    Rabbit Monoclonal Anti Cd31 Ihc, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd31/CD31+(PECAM-1)+XP+Rabbit+mAb/pm42981186-194-66-70
    Average 97 stars, based on 1 article reviews
    rabbit monoclonal anti cd31 ihc - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    98
    R&D Systems goat cd31
    Ocular tolerability following subconjunctival anti–Scg3 hAb administration. Mouse eyes were injected with either 80 µg or 2 mg of anti–Scg3 hAb and compared to PBS-treated and healthy eyes. ( A – C ) Images taken using the SMZ microscope ( A ) and OCT ( B ) were compared, and corneal thickness was quantified ( C ). ( D ) Corneal sensitivity was measured using the Cochet–Bonnet esthesiometer. ( E ) Blood vessels were immunostained using <t>anti-CD31.</t> Scale bar : 500 µm. ( F ) Vessel density was quantified. ( G , H ) Anti–ZO-1 was used for the immunostaining of tight junctions. Scale bar : 100 µm. ( I ) The number of corneal epithelial cells was counted. ( J ) Sodium fluorescein staining was used to verify the corneal epithelial integrity. Scale bar : 1000 µm. Data are presented as ±SEM; n = 5 corneas. P < 0.05 (one-way ANOVA).
    Goat Cd31, supplied by R&D Systems, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd31/Human%2FMouse%2FRat+CD31%2FPECAM-1+Antibody/pm42986759-93-10-15
    Average 98 stars, based on 1 article reviews
    goat cd31 - by Bioz Stars, 2026-11
    98/100 stars
      Buy from Supplier

    96
    Novus Biologicals cd31
    Ocular tolerability following subconjunctival anti–Scg3 hAb administration. Mouse eyes were injected with either 80 µg or 2 mg of anti–Scg3 hAb and compared to PBS-treated and healthy eyes. ( A – C ) Images taken using the SMZ microscope ( A ) and OCT ( B ) were compared, and corneal thickness was quantified ( C ). ( D ) Corneal sensitivity was measured using the Cochet–Bonnet esthesiometer. ( E ) Blood vessels were immunostained using <t>anti-CD31.</t> Scale bar : 500 µm. ( F ) Vessel density was quantified. ( G , H ) Anti–ZO-1 was used for the immunostaining of tight junctions. Scale bar : 100 µm. ( I ) The number of corneal epithelial cells was counted. ( J ) Sodium fluorescein staining was used to verify the corneal epithelial integrity. Scale bar : 1000 µm. Data are presented as ±SEM; n = 5 corneas. P < 0.05 (one-way ANOVA).
    Cd31, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd31/CD31%2FPECAM-1+Antibody/pmc13757799-93-21-23
    Average 96 stars, based on 1 article reviews
    cd31 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    98
    R&D Systems goat anti cd31
    a) Many angiogenic EC in Bead Assay (bead, yellow dashed circle) are positive for both (red arrowheads) nuclear Ovol1 (cyan) and nuclear Slug (green). b) Analysis of fluorescent intensity of individual angiogenic EC nuclei reveals a significant positive correlation between Ovol1 and Slug expression (pooled from sprouts from n=5 beads). To identify the spatial distribution of Ovol1 + EC within the sprout, c) we established quartiles relative to total sprout length. d) Compared to the distribution all EC nuclei across the sprout (which was relatively uniform), a significant difference was detected in spatial distribution of Ovol1 + EC, which appears to be driven primarily by enrichment of Ovol1 + EC in the distal sprout quartile (i.e., red, 75-100% of total sprout length), as well as lower than expected representation of Ovol1 + EC at the base of angiogenic sprouts (i.e., purple, 0-25% of total sprout length) (pooled from n=10 beads). (Statistics: Chi-Square Test).
    Goat Anti Cd31, supplied by R&D Systems, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd31/Human%2FMouse%2FRat+CD31%2FPECAM-1+Antibody/bio_rxiv__64898__2026__10__31__763143-50-2-5
    Average 98 stars, based on 1 article reviews
    goat anti cd31 - by Bioz Stars, 2026-11
    98/100 stars
      Buy from Supplier

    Image Search Results


    CD34 expression decreases in ageing‐associated AVS. (a) Schematic diagram showing the scRNA‐seq strategy of human aortic valves using data from the public database (PRJNA562645). (b) Left, UMAP plots of integrated scRNA‐seq datasets showing overall cell type and cluster distribution of human aortic valves (top left), and subtype and cluster distribution of valvular interstitial cell subpopulations (bottom left), from young and old patients. Coloured by cluster; Right, split UMAP plots of each group (VICs from young and old groups), coloured by cell cluster. (c) Stack bar plot showing the proportion of VIC subclusters in young and old cells. (d) Dot plot showing the representative DEGs for each VIC subcluster. (e) Bar plot showing the main enriched biological process in each VIC subcluster based on the significant DEGs from each subcluster. (f) Density plot of VIC subclusters in young and old groups across the pseudotime trajectory, coloured by VIC subcluster. (g) Violin plots displaying CD34 gene expression levels in the VIC subcluster for young and old groups. Statistical p values from Wilcoxon testing are added between the two groups. (h) CD34 gene expression trends across the pseudotime trajectory. (i) Representative immunohistochemical (IHC) images illustrating CD34 expression pattern in young and old aortic valves from mice, with magnified views of boxed regions. Dot plot (right) displayed the average optical density of CD34‐positive staining in aortic valves across different groups ( n = 6, unpaired two‐tailed Student's t‐test). Scale bars: 200 µm and 100 µm. (j) Western blotting of CD34 expression in aortic valves from young and old mice (upper panel), and control and D‐gal‐induced old mice (lower panel). (k) Quantification of fold changes associated with CD34 expression in AV tissues from young and old mice (left), and control and D‐gal induced old mice (right) ( n = 3, unpaired two‐tailed Student's t‐test). (l) Immunofluorescence (IF) staining demonstrating CD34 (red), CD31(green), and α SMA (grey) expression in AV tissues from human with sclerosis and stenosis, together with non‐sclerotic and non‐calcific AV tissues. Scale bars: 500 µm. Data are presented as the mean ± SEM. scRNA‐seq, single‐cell RNA sequencing; VICs, valvular interstitial cells; DEGs, differentially expressed genes.

    Journal: Advanced Science

    Article Title: CD34 + Progenitors Promote Ageing‐Associated Valve Sclerosis through the PDGFR–JNK–JUNB Pathway

    doi: 10.1002/advs.78607

    Figure Lengend Snippet: CD34 expression decreases in ageing‐associated AVS. (a) Schematic diagram showing the scRNA‐seq strategy of human aortic valves using data from the public database (PRJNA562645). (b) Left, UMAP plots of integrated scRNA‐seq datasets showing overall cell type and cluster distribution of human aortic valves (top left), and subtype and cluster distribution of valvular interstitial cell subpopulations (bottom left), from young and old patients. Coloured by cluster; Right, split UMAP plots of each group (VICs from young and old groups), coloured by cell cluster. (c) Stack bar plot showing the proportion of VIC subclusters in young and old cells. (d) Dot plot showing the representative DEGs for each VIC subcluster. (e) Bar plot showing the main enriched biological process in each VIC subcluster based on the significant DEGs from each subcluster. (f) Density plot of VIC subclusters in young and old groups across the pseudotime trajectory, coloured by VIC subcluster. (g) Violin plots displaying CD34 gene expression levels in the VIC subcluster for young and old groups. Statistical p values from Wilcoxon testing are added between the two groups. (h) CD34 gene expression trends across the pseudotime trajectory. (i) Representative immunohistochemical (IHC) images illustrating CD34 expression pattern in young and old aortic valves from mice, with magnified views of boxed regions. Dot plot (right) displayed the average optical density of CD34‐positive staining in aortic valves across different groups ( n = 6, unpaired two‐tailed Student's t‐test). Scale bars: 200 µm and 100 µm. (j) Western blotting of CD34 expression in aortic valves from young and old mice (upper panel), and control and D‐gal‐induced old mice (lower panel). (k) Quantification of fold changes associated with CD34 expression in AV tissues from young and old mice (left), and control and D‐gal induced old mice (right) ( n = 3, unpaired two‐tailed Student's t‐test). (l) Immunofluorescence (IF) staining demonstrating CD34 (red), CD31(green), and α SMA (grey) expression in AV tissues from human with sclerosis and stenosis, together with non‐sclerotic and non‐calcific AV tissues. Scale bars: 500 µm. Data are presented as the mean ± SEM. scRNA‐seq, single‐cell RNA sequencing; VICs, valvular interstitial cells; DEGs, differentially expressed genes.

    Article Snippet: Cell lines were authenticated by immunofluorescent staining (Vimentin, Abcam, ab8978; aSMA, Sigma, F3777) and confirmed by CD31 (R&D Systems, AF3628) immunofluorescent staining.

    Techniques: Expressing, Gene Expression, Immunohistochemical staining, Staining, Two Tailed Test, Western Blot, Control, Immunofluorescence, Single Cell, RNA Sequencing

    Lineage tracing revealing the contribution of CD34 + cells to myofibroblasts. (a) Schematic showing genetic lineage tracing using Cd34 ‐CreER T2 ;R26‐tdT mice. (b) Flow cytometric quantification comparing the percentage of tdTomato (tdT) + cells in PBMCs isolated from young (2‐mo) and old (24‐mo) Cd34 ‐CreER T2 ; R26‐tdT mice. (c) Representative whole‐mount immunostaining images showing tdTomato and CD31 in AV leaflets from young (2‐mo) and old (24‐mo) Cd34 ‐CreER T2 ; R26‐tdT mice. Scale bar, 200 µm. (d) Representative images of tdTomato, co‐staining with the activation of fibroblast marker periostin, and mesenchymal cell marker vimentin in young (2‐mo) and old (24‐mo) Cd34 ‐CreER T2 ; R26‐tdT mice, with boxed region showing magnification. Scale bars: 200, and 20 µm in magnification images. (e) Quantification of remaining tdT + cells in AV sections, illustrating the fraction of tdT + cells that participated in AV remodelling in the indicated group ( n = 6, unpaired two‐tailed Student's t‐test). (f) Quantification of the percentages of Periostin + tdT + cells in the Periostin + cells in the indicated group ( n = 6, unpaired two‐tailed Student's t‐test). (g) Schematic representation of primary CD34 + VICs isolation and the experimental strategy. (h) EDU assay showing cellular proliferation in aortic valvular CD34 − and CD34 + cells isolated from Cd34 ‐CreER T2 ;R26‐tdT mice, followed by TGF‐ β (10 ng/mL) and D‐gal (200 µg/mL) stimulation, scale bar: 100 µm. Dotplot (right) displaying the percentages of EDU + cells in primary valvular cells across different groups ( n = 10, two‐way ANOVA followed by Tukey post hoc test); Representative photographs of collagen gels taken at 18 h showing cells after TGF‐ β (10 ng/mL) and D‐gal (200 µg/mL). Scale bar: 1 mm. Quantification of gel diameters in indicated groups (right) ( n = 6, two‐way ANOVA followed by Tukey post hoc test); Representative transwell image showing cellular migration capacity of indicated cells in response to TGF‐ β (10 ng/mL) and D‐gal (200 µg/mL). Scale bar: 100 µm. Quantification (right) of cell counts in indicated groups ( n = 6, two‐way ANOVA followed by Tukey post hoc test). (i) Western blot showing the expression of CD34 and fibrosis‐related proteins in the indicated groups, with GAPDH as a loading control. Quantifications are shown on the right ( n = 3, two‐way ANOVA followed by Tukey post hoc test). (j) Representative IF staining images for periostin in indicated cells following TGF‐ β (10 ng/mL) and D‐gal (200 µg/mL) stimulation for 12 h. Scale bar: 20 µm. Data are presented as the mean ± SEM. R26, Rosa26; PBMC, peripheral blood mononuclear cells; CD31: Cluster of differentiation 31.

    Journal: Advanced Science

    Article Title: CD34 + Progenitors Promote Ageing‐Associated Valve Sclerosis through the PDGFR–JNK–JUNB Pathway

    doi: 10.1002/advs.78607

    Figure Lengend Snippet: Lineage tracing revealing the contribution of CD34 + cells to myofibroblasts. (a) Schematic showing genetic lineage tracing using Cd34 ‐CreER T2 ;R26‐tdT mice. (b) Flow cytometric quantification comparing the percentage of tdTomato (tdT) + cells in PBMCs isolated from young (2‐mo) and old (24‐mo) Cd34 ‐CreER T2 ; R26‐tdT mice. (c) Representative whole‐mount immunostaining images showing tdTomato and CD31 in AV leaflets from young (2‐mo) and old (24‐mo) Cd34 ‐CreER T2 ; R26‐tdT mice. Scale bar, 200 µm. (d) Representative images of tdTomato, co‐staining with the activation of fibroblast marker periostin, and mesenchymal cell marker vimentin in young (2‐mo) and old (24‐mo) Cd34 ‐CreER T2 ; R26‐tdT mice, with boxed region showing magnification. Scale bars: 200, and 20 µm in magnification images. (e) Quantification of remaining tdT + cells in AV sections, illustrating the fraction of tdT + cells that participated in AV remodelling in the indicated group ( n = 6, unpaired two‐tailed Student's t‐test). (f) Quantification of the percentages of Periostin + tdT + cells in the Periostin + cells in the indicated group ( n = 6, unpaired two‐tailed Student's t‐test). (g) Schematic representation of primary CD34 + VICs isolation and the experimental strategy. (h) EDU assay showing cellular proliferation in aortic valvular CD34 − and CD34 + cells isolated from Cd34 ‐CreER T2 ;R26‐tdT mice, followed by TGF‐ β (10 ng/mL) and D‐gal (200 µg/mL) stimulation, scale bar: 100 µm. Dotplot (right) displaying the percentages of EDU + cells in primary valvular cells across different groups ( n = 10, two‐way ANOVA followed by Tukey post hoc test); Representative photographs of collagen gels taken at 18 h showing cells after TGF‐ β (10 ng/mL) and D‐gal (200 µg/mL). Scale bar: 1 mm. Quantification of gel diameters in indicated groups (right) ( n = 6, two‐way ANOVA followed by Tukey post hoc test); Representative transwell image showing cellular migration capacity of indicated cells in response to TGF‐ β (10 ng/mL) and D‐gal (200 µg/mL). Scale bar: 100 µm. Quantification (right) of cell counts in indicated groups ( n = 6, two‐way ANOVA followed by Tukey post hoc test). (i) Western blot showing the expression of CD34 and fibrosis‐related proteins in the indicated groups, with GAPDH as a loading control. Quantifications are shown on the right ( n = 3, two‐way ANOVA followed by Tukey post hoc test). (j) Representative IF staining images for periostin in indicated cells following TGF‐ β (10 ng/mL) and D‐gal (200 µg/mL) stimulation for 12 h. Scale bar: 20 µm. Data are presented as the mean ± SEM. R26, Rosa26; PBMC, peripheral blood mononuclear cells; CD31: Cluster of differentiation 31.

    Article Snippet: Cell lines were authenticated by immunofluorescent staining (Vimentin, Abcam, ab8978; aSMA, Sigma, F3777) and confirmed by CD31 (R&D Systems, AF3628) immunofluorescent staining.

    Techniques: Lineage Tracing, Isolation, Immunostaining, Staining, Activation Assay, Marker, Two Tailed Test, EdU Assay, Migration, Western Blot, Expressing, Control

    Ocular tolerability following subconjunctival anti–Scg3 hAb administration. Mouse eyes were injected with either 80 µg or 2 mg of anti–Scg3 hAb and compared to PBS-treated and healthy eyes. ( A – C ) Images taken using the SMZ microscope ( A ) and OCT ( B ) were compared, and corneal thickness was quantified ( C ). ( D ) Corneal sensitivity was measured using the Cochet–Bonnet esthesiometer. ( E ) Blood vessels were immunostained using anti-CD31. Scale bar : 500 µm. ( F ) Vessel density was quantified. ( G , H ) Anti–ZO-1 was used for the immunostaining of tight junctions. Scale bar : 100 µm. ( I ) The number of corneal epithelial cells was counted. ( J ) Sodium fluorescein staining was used to verify the corneal epithelial integrity. Scale bar : 1000 µm. Data are presented as ±SEM; n = 5 corneas. P < 0.05 (one-way ANOVA).

    Journal: Investigative Ophthalmology & Visual Science

    Article Title: Subconjunctival Injection of Anti-Secretogranin III Mitigates Corneal Damage in Alkali Burn Injury Model

    doi: 10.1167/iovs.67.13.15

    Figure Lengend Snippet: Ocular tolerability following subconjunctival anti–Scg3 hAb administration. Mouse eyes were injected with either 80 µg or 2 mg of anti–Scg3 hAb and compared to PBS-treated and healthy eyes. ( A – C ) Images taken using the SMZ microscope ( A ) and OCT ( B ) were compared, and corneal thickness was quantified ( C ). ( D ) Corneal sensitivity was measured using the Cochet–Bonnet esthesiometer. ( E ) Blood vessels were immunostained using anti-CD31. Scale bar : 500 µm. ( F ) Vessel density was quantified. ( G , H ) Anti–ZO-1 was used for the immunostaining of tight junctions. Scale bar : 100 µm. ( I ) The number of corneal epithelial cells was counted. ( J ) Sodium fluorescein staining was used to verify the corneal epithelial integrity. Scale bar : 1000 µm. Data are presented as ±SEM; n = 5 corneas. P < 0.05 (one-way ANOVA).

    Article Snippet: The corneas were then incubated in antibody solution containing primary antibodies DyLight 550–conjugated anti–CD31 mAb (NB100-1642R, 1:100 dilution; Novus Biologicals) and Alexa Fluor 488–conjugated anti–lymphatic vessel endothelial receptor 1 (LYVE1) mAb (54-0443-82, 1:100 dilution; Life Technologies, Carlsbad, CA, USA) for 3 days at 4°C, followed by PBS wash and nuclear staining using Hoechst stain solution (62269, 1:1000 dilution; Thermo Fisher Scientific).

    Techniques: Injection, Microscopy, Sensitivity, Immunostaining, Staining

    Therapeutic effects on neovascularization. ( A ) Representative images comparing the neovascularization ( arrows indicate CoNV), including healthy, alkali burn only (untreated), or treated with PBS, aflibercept, or anti–Scg3 hAb, respectively. ( B – D ) Neovascularization on the corneas was clinically scored and represented as a neovascularization score ( B ), and the number of blood vessels ( C ) and total length of blood vessels ( D ) were also quantified ( n = 10 corneas per group). ( E – H ) Representative flatmount images of the whole cornea labeled with anti-CD31 ( red indicates blood vessels) and anti-LYVE1 ( green indicates lymph vessels) on day 10 after the burn. ( I , J ) Quantification of blood vessel density ( I ) and lymphatic vessel density ( J ) on day 10 after the burn ( n = 3 corneas per group). Scale bar : 100 µm. Data are presented as ±SEM. P < 0.05 (one-way ANOVA).

    Journal: Investigative Ophthalmology & Visual Science

    Article Title: Subconjunctival Injection of Anti-Secretogranin III Mitigates Corneal Damage in Alkali Burn Injury Model

    doi: 10.1167/iovs.67.13.15

    Figure Lengend Snippet: Therapeutic effects on neovascularization. ( A ) Representative images comparing the neovascularization ( arrows indicate CoNV), including healthy, alkali burn only (untreated), or treated with PBS, aflibercept, or anti–Scg3 hAb, respectively. ( B – D ) Neovascularization on the corneas was clinically scored and represented as a neovascularization score ( B ), and the number of blood vessels ( C ) and total length of blood vessels ( D ) were also quantified ( n = 10 corneas per group). ( E – H ) Representative flatmount images of the whole cornea labeled with anti-CD31 ( red indicates blood vessels) and anti-LYVE1 ( green indicates lymph vessels) on day 10 after the burn. ( I , J ) Quantification of blood vessel density ( I ) and lymphatic vessel density ( J ) on day 10 after the burn ( n = 3 corneas per group). Scale bar : 100 µm. Data are presented as ±SEM. P < 0.05 (one-way ANOVA).

    Article Snippet: The corneas were then incubated in antibody solution containing primary antibodies DyLight 550–conjugated anti–CD31 mAb (NB100-1642R, 1:100 dilution; Novus Biologicals) and Alexa Fluor 488–conjugated anti–lymphatic vessel endothelial receptor 1 (LYVE1) mAb (54-0443-82, 1:100 dilution; Life Technologies, Carlsbad, CA, USA) for 3 days at 4°C, followed by PBS wash and nuclear staining using Hoechst stain solution (62269, 1:1000 dilution; Thermo Fisher Scientific).

    Techniques: Labeling

    a) Many angiogenic EC in Bead Assay (bead, yellow dashed circle) are positive for both (red arrowheads) nuclear Ovol1 (cyan) and nuclear Slug (green). b) Analysis of fluorescent intensity of individual angiogenic EC nuclei reveals a significant positive correlation between Ovol1 and Slug expression (pooled from sprouts from n=5 beads). To identify the spatial distribution of Ovol1 + EC within the sprout, c) we established quartiles relative to total sprout length. d) Compared to the distribution all EC nuclei across the sprout (which was relatively uniform), a significant difference was detected in spatial distribution of Ovol1 + EC, which appears to be driven primarily by enrichment of Ovol1 + EC in the distal sprout quartile (i.e., red, 75-100% of total sprout length), as well as lower than expected representation of Ovol1 + EC at the base of angiogenic sprouts (i.e., purple, 0-25% of total sprout length) (pooled from n=10 beads). (Statistics: Chi-Square Test).

    Journal: bioRxiv

    Article Title: An Ovol1 Variant in Endothelial Cells Regulates Slug and is Essential for Pathological Angiogenesis

    doi: 10.64898/2026.10.31.763143

    Figure Lengend Snippet: a) Many angiogenic EC in Bead Assay (bead, yellow dashed circle) are positive for both (red arrowheads) nuclear Ovol1 (cyan) and nuclear Slug (green). b) Analysis of fluorescent intensity of individual angiogenic EC nuclei reveals a significant positive correlation between Ovol1 and Slug expression (pooled from sprouts from n=5 beads). To identify the spatial distribution of Ovol1 + EC within the sprout, c) we established quartiles relative to total sprout length. d) Compared to the distribution all EC nuclei across the sprout (which was relatively uniform), a significant difference was detected in spatial distribution of Ovol1 + EC, which appears to be driven primarily by enrichment of Ovol1 + EC in the distal sprout quartile (i.e., red, 75-100% of total sprout length), as well as lower than expected representation of Ovol1 + EC at the base of angiogenic sprouts (i.e., purple, 0-25% of total sprout length) (pooled from n=10 beads). (Statistics: Chi-Square Test).

    Article Snippet: For immunofluorescence: Goat anti-CD31 (1:200, R&D #AF3628); Rabbit anti-Ovol1 (1:500, Proteintech #14082-1-AP); Mouse anti-Slug (1:300, Santa Cruz #sc-166476); Mouse anti-αSMA (1:500, Sigma #A5228); Rabbit anti-ERG Alexa fluor 647 (1:200, Abcam #ab196149); Donkey anti-Goat Alexa fluor 647 (1:200 - 1:600, Invitrogen #A21447); Donkey anti-rabbit Alexa fluor 594 (1:200 - 1:600, Invitrogen #A21207); Donkey anti-mouse Alexa fluor 488 (1:200 - 1:600, Invitrogen #A21202).

    Techniques: Analysis, Expressing, Chi-Square

    a) si-Ovol1 HUVEC fail to sprout in Bead Assay (bead, dashed circle) at Day 6 compared to si-Ctrl HUVEC, quantified as significant decreases in mean b) sprout number and c) sprout length (n=63 si-Ctrl, n=101 si-Ovol1 beads pooled across 9 independent replicates). (Statistics: Unpaired Students’ t-test) d) Ovol1 OE HUVEC undergo more aggressive sprouting compared to control (eGFP) HUVEC, quantified as significantly increased e) sprout number and f) sprout length (n=13 beads per group pooled across 3 independent replicates). (Statistics: Unpaired Students’ t-test). g) Silencing of endogenous Slug expression (via si-Slug) in Ovol1 OE HUVEC rescued both h) sprout number and i) sprout length compared to Ovol1 OE cells transfected with a non-targeting siRNA control (si-Ctrl). (n=12 beads per group pooled across 3 independent replicates). (Statistics: 1-way ANOVA with post hoc t-test adjusted for multiple comparisons).

    Journal: bioRxiv

    Article Title: An Ovol1 Variant in Endothelial Cells Regulates Slug and is Essential for Pathological Angiogenesis

    doi: 10.64898/2026.10.31.763143

    Figure Lengend Snippet: a) si-Ovol1 HUVEC fail to sprout in Bead Assay (bead, dashed circle) at Day 6 compared to si-Ctrl HUVEC, quantified as significant decreases in mean b) sprout number and c) sprout length (n=63 si-Ctrl, n=101 si-Ovol1 beads pooled across 9 independent replicates). (Statistics: Unpaired Students’ t-test) d) Ovol1 OE HUVEC undergo more aggressive sprouting compared to control (eGFP) HUVEC, quantified as significantly increased e) sprout number and f) sprout length (n=13 beads per group pooled across 3 independent replicates). (Statistics: Unpaired Students’ t-test). g) Silencing of endogenous Slug expression (via si-Slug) in Ovol1 OE HUVEC rescued both h) sprout number and i) sprout length compared to Ovol1 OE cells transfected with a non-targeting siRNA control (si-Ctrl). (n=12 beads per group pooled across 3 independent replicates). (Statistics: 1-way ANOVA with post hoc t-test adjusted for multiple comparisons).

    Article Snippet: For immunofluorescence: Goat anti-CD31 (1:200, R&D #AF3628); Rabbit anti-Ovol1 (1:500, Proteintech #14082-1-AP); Mouse anti-Slug (1:300, Santa Cruz #sc-166476); Mouse anti-αSMA (1:500, Sigma #A5228); Rabbit anti-ERG Alexa fluor 647 (1:200, Abcam #ab196149); Donkey anti-Goat Alexa fluor 647 (1:200 - 1:600, Invitrogen #A21447); Donkey anti-rabbit Alexa fluor 594 (1:200 - 1:600, Invitrogen #A21207); Donkey anti-mouse Alexa fluor 488 (1:200 - 1:600, Invitrogen #A21202).

    Techniques: Control, Expressing, Transfection